Statistics

Research Cancer Immunotherapy | Genentech Oncology

www.researchcancerimmunotherapy.com/

Explore cancer immunotherapy research from Genentech BioOncology, including pathways and tumor types under investigation and clinical trials.

Researchcancerimmunotherapy.com

Conversion Technology Metas Server

Researchcancerimmunotherapy.com is hosted in United States / San Francisco . Researchcancerimmunotherapy.com uses HTTPS protocol. Number of used technologies: 5. First technologies: CSS, Google Font API, Html, Number of used javascripts: 1. First javascripts: App.js, Number of used analytics tools: 1. First analytics tools: Google Analytics, Its server type is: .

Technologies in use by Researchcancerimmunotherapy.com

Technology

Number of occurences: 5

CSS
Google Font API
Html
Html5
Javascript

Javascripts

Number of occurences: 1

app.js

Analytics

Number of occurences: 1

Google Analytics

Server Type

Google Analytics ID

UA-59645556-1

Conversion rate optimization
Clickable call number	Not founded!
Conversion form (contact form, subcriber)	Not founded!
Clickable email	Not founded!
CTA (call to action) button	Founded!
List	Founded!
Image	Not founded!
Enhancement	Not founded!
Responsive website	Founded!
Facebook sharing	Not founded!
Google+ sharing	Not founded!
Twitter sharing	Not founded!
Linkedin sharing	Not founded!
Blog on the webiste	Not founded!

HTTPS (SSL) - Researchcancerimmunotherapy.com

SSL certificate

name: /OU=GT53269810/OU=See www.geotrust.com/resources/cps (c)15/OU=Domain Control Validated - QuickSSL(R) Premium/CN=www.researchcancerimmunotherapy.com
subject:
- OU:
  - 0: GT53269810
  - 1: See www.geotrust.com/resources/cps (c)15
  - 2: Domain Control Validated - QuickSSL(R) Premium
- CN: www.researchcancerimmunotherapy.com
hash: 3a9c55db
issuer:
- C: US
- O: GeoTrust Inc.
- OU: Domain Validated SSL
- CN: GeoTrust DV SSL CA - G4
version: 2
serialNumber: 72542
validFrom: 150414110836Z
validTo: 170416091842Z
validFrom_time_t: 1429009716
validTo_time_t: 1492334322
extensions:
- authorityKeyIdentifier: keyid:0B:50:EC:77:EF:2A:9B:FF:EC:03:A1:0A:FF:AD:C6:E4:2A:18:C7:3E
- authorityInfoAccess: OCSP - URI:http://gu.symcd.com CA Issuers - URI:http://gu.symcb.com/gu.crt
- keyUsage: Digital Signature, Key Encipherment
- extendedKeyUsage: TLS Web Server Authentication, TLS Web Client Authentication
- subjectAltName: DNS:www.researchcancerimmunotherapy.com, DNS:researchcancerimmunotherapy.com
- crlDistributionPoints: Full Name: URI:http://gu.symcb.com/gu.crl
- basicConstraints: CA:FALSE
- certificatePolicies: Policy: 2.23.140.1.2.1 CPS: https://www.geotrust.com/resources/repository/legal

Meta - Researchcancerimmunotherapy.com

Number of occurences: 5

Name:
Content:
Name: description
Content: Explore cancer immunotherapy research from Genentech BioOncology, including pathways and tumor types under investigation and clinical trials.
Name: keywords
Content: cancer immunotherapy, immunotherapy research, pathways, cancer clinical trials, cancer research, oncology clinical trials, Genentech, BioOncology, Genentech oncology, immunogenic cancers, PD-L1
Name: viewport
Content: width=device-width, initial-scale=1
Name: format-detection
Content: telephone=no

Server / Hosting

IP: 72.34.128.87
Latitude: 37.72
Longitude: -122.44
Country: United States
City: San Francisco

Rname

dnadns3e.gene.com
dnadns4e.gene.com
dnadns2e.gene.com

Target

postmaster.no.email.please

HTTP Header Response

HTTP/1.1 200 OK Date: Thu, 21 Jul 2016 03:35:41 GMT Content-Disposition: inline;filename="index.html" Accept-Ranges: bytes ETag: /_1468971077917 Last-Modified: Tue, 19 Jul 2016 23:31:17 GMT Content-Range: bytes 0-11866/11866 Content-Length: 11866 Content-Type: text/html;charset=UTF-8 Content-Language: en Set-Cookie: BIGipServerws_products_pool=dcW2IsMzmLhqpPbBcUhhssE61/YjhA/a8xglr/xtaxekv66e4s+RnOnnFXFuO9jleaNIJwdhGfuaEQ==; path=/ X-Cache: MISS from s_hp65 X-Cache-Lookup: MISS from s_hp65:80 Via: 1.1 s_hp65 (squid/3.5.19) Connection: keep-alive